Adding product to your cart
Experience the freedom of movement with Arthroclem, a comprehensive joint support supplement. Arthroclem's unique blend of eight scientifically researched ingredients works synergistically to promote healthy joint function and mobility. This powerful formula includes Glucosamine Sulfate, Chondroitin Sulfate, MSM (Methylsulfonylmethane), Collagen Type II, and Flaxseed, all known for their ability to support joint health and reduce inflammation.
Manufactured in an FDA-inspected facility, Arthroclem is held to the highest quality standards. Since its introduction in 2002, Arthroclem boasts an excellent safety record with no reported adverse events.
Key Features:
-
Clinically Supported Ingredients: Glucosamine Sulfate, Chondroitin Sulfate, MSM, Collagen Type II & Flaxseed work together to support healthy joints.
-
Reduces Inflammation: This powerful formula helps reduce inflammation associated with joint discomfort.
-
Promotes Mobility: Experience improved flexibility and a wider range of motion.
-
Safe & Effective: Manufactured in an FDA-inspected facility with a history of safe use.
-
Daily Support: Formulated for daily use to maintain healthy joints and mobility.
INGREDIENTS
- Glucosamine 300 mg
- Chondroitin Sulfate 200 mg
- MSM 200 mg
- Chicken Collagen Type II 100 mg
- Flaxseed 100 mg
- Bromelain 30 mg
- Boswellia 10 mg
- Curcumin 10 mg
References
- White RR, Crawley FE, Vellini M, et al. Bioavailability of 125I bromelain after oral administration to rats. Biopharm Drug Dispos 1988;9:397-403.
- Kumakura S, Yamashita M, Tsurufuji S. Effect of bromelain on kaolin-induced inflammation in rats. Eur J Pharmacol 1988;150:295-301.
- Uchida Y, Katori M. Independent consumption of high and low molecular weight kininogens in vivo. Adv Exp Med Biol 1986;198:113-118.
- Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988;22:191-203.
- Felton GE. Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. Med Hypotheses 1980;6:1123-1133.6. Heinicke RM, Van der Wal M, Yokoyama MM. Effect of bromelain (Ananase) on human platelet aggregation. Experientia 1972;28:844-845.
- De-Giuli M, Pirotta F. Bromelain: interaction with some protease inhibitors and rabbit specific antiserum. 8 Drugs ExpClin Res 1978;4:21-23.
- Taussig SJ, Yokoyama MM, Chinen N, et al. Bromelain: A proteolytic enzyme and its clinical application. Hiroshima J Med Sci 1975;24:185-193.
SHARE
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device